Head of School of Medical Sciences
Tony Heagerty obtained his medical degree from UCL and his MD in Leicester. He won the International Society of Hypertension Outstanding Young Investigator Award and delivered the Royal College of Physicians’ Goulstonian Lecture. He was Medical Director of the Manchester Wellcome Trust Clinical Research Facility until 2011.
He is a former President of the European Society of Hypertension and the International Society of Hypertension. He served as a Member of the British Heart Foundation until 2010. In 2009, he was elected Vice-President of the British Hypertension Society and is currently the serving President.
Professor Heagerty was a Founding Member of the Academy of Medical Sciences and formerly a Member of the Academic Medicine Committee. He serves on the Nominations Committee of the Royal College of Physicians.
He has editorial board commitments to Hypertension, Journal of Clinical Metabolism & Diabetes, Therapeutic Advances in Cardiovascular Disease, The Open Cardiovascular Medicine Journal, Experimental Physiology, Current Hypertension Reviews, Hypertension, Diabetes and Vascular Disease Research and Blood Pressure.
Professor Heagerty is a grant reviewer for Health Boards in New Zealand, France, Holland and in the United Kingdom. In 2006, he was the Folkow Lecturer for the European Society of Hypertension and Lecturer of the Year in Belgium.
His clinical interests are in high blood pressure and cardiovascular diseases. Most recently, he led the successful application to designate Manchester as a European Society of Hypertension Centre of Excellence and introduced renal denervation in collaboration with the Department of Radiology and the Manchester Heart Centre at Central Manchester Healthcare Trust.
He is an international authority on high blood pressure and is regularly invited to give lectures at international meetings.
Professor Heagerty holds an Honorary Consultant contract with Central Manchester Healthcare Trust (Manchester Royal Infirmary). He holds regular clinics for the treatment of high blood pressure, as well as general and internal medicine. He is a member of the Institute of Health Sciences Diabetes and Obesity Research Network. He is also a Fellow of the High Blood Pressure Council of the American Heart Association.